论文部分内容阅读
目的 探析白内障术后干眼症患者采用0.3%玻璃酸钠滴眼液进行辅助治疗的临床疗效及意义.方法 分析2015年12月~2016年6月在武警总医院院接受白内障超声乳化术+人工晶体植入术治疗的42例单纯性年龄相关性白内障患者的临床资料.随机将入选者分成观察组(常规治疗+0.3%玻璃酸钠滴眼液,22例)和对照组(常规治疗,20例)两组.比较两组患者的一般资料、手术前后的泪膜破裂时间(BUT)、泪河高度(TMH)、泪液分泌试验(Slt)、角膜荧光素染色(FL)、干眼主观症状评分及眼表疾病指数(OSDI)问卷评分.结果 两组患者的一般资料无显著差异(P>0.05).术前,两组患者的BUT、TMH、Slt均无显著差异(P>0.05),但观察组FL值明显高于对照组(P0.05), but the FL score in observe group was obviously higher than that in control group (P0.05), and had no difference from those of the same group before treatment (P>0.05). At 4 weeks after treatment, the FL score in observe group and the BUT value in control group were both obviously lower than those before treatment (P<0.05), and the value of BUT in observe group was obviously higher than that in control group (P0.05). But the dry eye subjective symptom scores and OSDI scores at 1, 4 weeks after treatment in observe group or control group were all obviously lower than those before treatment in the same group(P<0.05). Conclusion The adjuvant therapy of 0.3%sodium hyaluronate eye drops in dry eye disease patients after phacoemulsification can obviously promote the recovery of postoperative corneal epithelial and enhance the tear film stability, which plays a motivating role in helping ocular surface function to recover.